论文部分内容阅读
自王清任创制补阳还五汤以来，其临床应用广泛，疗效显著，是目前中风等血栓性疾病应用频率最高的方剂［１］。血小板活化因子（ｐｌａｔｅｌｅｔ ａｃｔｉｖａｔｉｎｇ ｆａｃｔｏｒ，ＰＡＦ）是迄今发现的体内最强的血小板聚集剂，与血栓形成密切相关［２］。本研究应用大鼠
Since Wang Qingren’s creation of Buyang Huanwu Decoction, its clinical application has been extensive and its curative effect has been remarkable. It is currently the most frequently applied prescription for stroke and other thrombotic diseases [1]. Platelet activating factor (PAF) is the most powerful platelet aggregation agent found in the body so far and is closely related to thrombosis [2]. This study uses rats